Disclosure Of Interests In Other Entities [Text Block]

Cinclus Pharma Holding AB - Filing #5879290

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—		—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	600 467 SEK	—	—	—	—	—	—	94 091 SEK	—	—	—
Non-current assets	—	—	546,000 SEK	—	—	—	—	—	—	322,000 SEK	—	—	—
Current liabilities	—	—	45 493 SEK	—	—	—	—	—	—	164 422 SEK	—	—	—
Non-current liabilities	—	—	190,000 SEK	—	—	—	—	—	—	6 790 SEK	—	—	—
Profit (loss)	– SEK	168 031 SEK	—	– SEK	– SEK	168 031 SEK	– SEK	– SEK	215 118 SEK	—	215 118 SEK	– SEK	—
Comprehensive income	– SEK	165 367 SEK	—	2 664 SEK	– SEK	168 031 SEK	– SEK	– SEK	205 951 SEK	—	215 118 SEK	9 167 SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	– SEK	2 664 SEK	—	2 664 SEK	– SEK	– SEK	– SEK	– SEK	9 167 SEK	—	– SEK	9 167 SEK	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	566 716 SEK	—	—	—	—	—	—	87 972 SEK	—	—	173 546 SEK